BAM15

Fat LossMitochondrial uncoupler / small moleculeExperimental

Mitochondrial protonophore uncoupler used in metabolic research to increase energy expenditure independently of beta-oxidation stimulation. Not FDA-approved; not a peptide.

Calculate Dose

For research use only.

Key Facts

CAS
210302-17-3
Molecular Weight (MW)
340.29 g/mol
Half-life
Not established (limited public PK; primarily preclinical/in vitro characterization)
Unit
mg
Administration Route
In vitro / preclinical research use (route varies by study design)
Frequency
Not established
Last updated
8/23/2026
Targets
Mitochondrial inner membrane

Overview

Mitochondrial protonophore uncoupler used in metabolic research to increase energy expenditure independently of beta-oxidation stimulation. Not FDA-approved; not a peptide.

Protocol

Dosage Range
Not established (research-only)
Frequency
Not established
Cycle
Not established (research compound; do not self-administer)
Administration Route
In vitro / preclinical research use (route varies by study design)
Reconstitution Guide
Typically dissolved in DMSO for lab use; follow COA/MSDS and lab SOPs

Science

Mechanism of Action

Increases inner-mitochondrial-membrane proton leak, uncoupling oxidative phosphorylation from ATP synthesis and raising energy expenditure in cells and rodents without the classic DNP-like off-target toxicity profile in published models.

Targets

Mitochondrial inner membrane

Studies

Benefits

Metabolic-rate research toolObesity/diabetes models

Potential Side Effects

  • Hyperthermia risk class-effect of uncouplers
  • No approved human dose

References

Related peptides